Acupuncture’s Role in Resolving GLP-1 Drug-Induced Blindness

This article shines a light on the alarming ocular complication associated with GLP-1 receptor agonists (such as semaglutide and liraglutide): Non-arteritic Anterior Ischemic Optic Neuropathy (NAION). NAION is a serious condition causing sudden vision loss due to reduced blood flow and optic nerve damage. Troubling research indicates that semaglutide may approximately double the risk of NAION. Given the massive projected use of these weight loss drugs, the article warns that thousands of individuals could face NAION-related blindness. The underlying cause involves vascular dysregulation and optic nerve ischemia. Acupuncturists are urged to remain vigilant and counsel patients, particularly those with diabetes or hypertension, about this risk. Acupuncture is presented as a promising and viable therapeutic intervention for NAION. Controlled trials demonstrate its ability to improve vision outcomes in ischemic optic neuropathy by enhancing microcirculation, neuroprotection, and modulation of vascular tone. Specific local and distal acupoints are frequently used, including UB 1 (Jingming) and GB 20 (Fengchi), to promote ocular blood flow and nerve regeneration. Acupuncture offers a cost-effective solution with a low side effect profile for managing these associated ocular vascular insufficiencies.